Related Experiment Video
Updated: Dec 2, 2025

03:37
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
1.1K
Unsupervised and supervised learning with neural network for human transcriptome analysis and cancer diagnosis
Bo Yuan1,2,3, Dong Yang4,5, Bonnie E G Rothberg6
1Department of Genetics, Yale Cancer Center, Howard Hughes Medical Institute, Yale University School of Medicine, 295 Congress Avenue, New Haven, CT, 06510, USA.
Scientific Reports
|November 6, 2020
Summary
Deep learning effectively analyzes transcriptomic data using DeepT2Vec, a novel autoencoder. This method accurately distinguishes normal and tumor tissues, advancing cancer diagnostics with transcriptomic feature vectors (TFVs).
Area of Science:
- Computational Biology
- Bioinformatics
- Genomics
Background:
- Transcriptomic data analysis is crucial for understanding biological and pathological changes.
- The structural complexity of transcriptomic data presents unique challenges compared to image and text data.
- Current methods may struggle with the nuanced analysis of large-scale transcriptomic datasets.
Purpose of the Study:
- To develop a deep learning approach for analyzing complex human transcriptomic data.
- To create informative feature representations from transcriptomic data using an autoencoder.
- To evaluate the efficacy of these features in distinguishing normal and tumor tissues.
Main Methods:
- Unsupervised training of a Deep-Autoencoder (DeepT2Vec) on over 20,000 human normal and tumor transcriptomic datasets.
- Extraction of 30-dimensional Transcriptomic Feature Vectors (TFVs) from the transcriptomic data.
- Development and training of a supervised classifier (DeepC) using the extracted TFVs.
Main Results:
- DeepT2Vec successfully extracted informative features and embedded transcriptomes into 30-dimensional TFVs.
- TFVs accurately recapitulated expression patterns and could track tissue origins.
- DeepC achieved 90% accuracy for Pan-Cancer and 94% average accuracy for specific cancers in distinguishing normal from tumor samples.
- Further accuracy improvements to 96% for Pan-Cancer were observed when training on a connected network.
Conclusions:
- Deep learning, particularly using autoencoders, is a suitable method for transcriptomic data analysis.
- DeepT2Vec provides effective transcriptomic feature extraction for biological analysis.
- The developed approach demonstrates significant potential for classifying cancers and normal tissues, even with limited samples.

